Liver Cirrhosis Withdrawn Phase 4 Trials for Ambrisentan (DB06403)

Also known as: Cirrhosis, Liver / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0028911 (Liver Cirrhosis)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03309592Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary HypertensionTreatment